CITATION STYLE
Honore, P. M., Barreto Gutierrez, L., Kugener, L., Redant, S., Attou, R., Gallerani, A., & De Bels, D. (2020, October 9). Infliximab can reduce mortality from 35 to 14% in critically ill patients with COVID-19: Perhaps some potential confounders to consider. Critical Care. BioMed Central Ltd. https://doi.org/10.1186/s13054-020-03294-7
Mendeley helps you to discover research relevant for your work.